Word: healthful
(lookup in dictionary)
(lookup stats)
Dates: during 1980-1989
Sort By: most recent first
(reverse)
...Senator, but Minnesota Republican Dave Durenberger is not known as a best-selling author. So why did his books on health care and national-security policy show such a hefty profit...
Congress, industry and consumer groups agree that something needs to be done to resuscitate the ailing agency. Young is a victim of the urge for change: last month Health and Human Services Secretary Louis Sullivan said he was transferring Young to a new post -- Deputy Assistant Secretary of Health for Health Science and Environment -- effective this week. The position was created especially for Young, and is widely regarded as a demotion...
...shortfall is worsening. Among other things, Congress reacted to the Reagan cutbacks by passing 23 public health bills during the '80s, many of them efforts to shore up the FDA's powers. The action significantly expanded the FDA's workload. Yet Congress never moved to restore a single lost staff position or add employees to meet the increased responsibilities. The advent of an entirely new industry, biotechnology, demanded an FDA response to more than 950 genetically engineered products during the 1980s...
...pressures have also played a role. As AIDS has spread, protesters have charged that the agency has been keeping lifesaving drugs out of the hands of victims. In fact, the FDA spent $5 million more than the $46 million Congress provided to seek a cure for the disease. With health-conscious Americans including less red meat in their diets, the FDA's thin line of inspectors has been forced to monitor increasing amounts of seafood, imported fruits and vegetables, and chicken and eggs. A number of spectacular food- tampering cases, like last March's poisoned Chilean grape case (only...
Amid all the institutional turmoil, Secretary Sullivan's decision to push out Commissioner Young has been especially inept. Sullivan has no replacement waiting, and in fact has been unable to fill many important health jobs because White House conservatives filter out nominees with proabortion views. Pro-lifers are sure to scrutinize Young's successor closely since the agency is likely to decide on approving new abortion-inducing drugs like RU 486, the pill manufactured by a French subsidiary of Hoechst...